major adverse cardiovascular events

Victoria SochaChronic Kidney Disease | May 29, 2025

A dual SGLT inhibitor may have ischemic benefits for patients with CKD, T2D, and cardiovascular risks, a study found.

DocWire News EditorsCardiology | September 12, 2019

Endothelial dysfunction induced by mental stress was associated in a graded fashion with an increase in the incidence of ...

DocWire News EditorsCardiology | April 19, 2019

This week's edition includes some troubling findings for statins, good things happening with canagliflozin, a new add-on ...

Kaitlyn D’OnofrioRheumatology | April 25, 2023

Here are the top stories covered by DocWire News this week in the Rheumatology section. In this edition, learn about ...

DocWire News EditorsACC 2018 Conference | April 11, 2023

In patients who recently suffered an acute coronary syndrome (ACS), the PCSK9 inhibitor alirocumab was associated with a ...